Stay updated on INCAGN01876 Combo Immune Therapies Clinical Trial

Sign up to get notified when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the INCAGN01876 Combo Immune Therapies Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations section updated to expand participating sites across the US and Australia, including Chevigny and multiple state/territory entries. The update is labeled as Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T09:22:16.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Only the revision label in the page footer changed from v3.3.1 to v3.3.2; no study details, eligibility criteria, or results were altered.
    Difference
    0.0%
    Check dated 2025-12-01T17:49:33.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Footer Revision updated from v3.2.0 to v3.3.1. No changes to study data, eligibility criteria, or listed locations.
    Difference
    0.0%
    Check dated 2025-11-24T14:46:38.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The funding outage notice was removed from the page, a non-significant change that does not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T07:33:01.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The page now includes updated study results and outcome measures across phases, including ORR, DOR, PFS, and OS. Safety data and related study documents are also provided.
    Difference
    0.2%
    Check dated 2025-11-03T01:27:02.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Update includes a new version tag (v3.2.0) and a government operating-status notice, while removing two disease terms (Small cell lung carcinoma, Cutaneous neuroendocrine carcinoma).
    Difference
    1%
    Check dated 2025-10-05T12:52:05.000Z thumbnail image

Stay in the know with updates to INCAGN01876 Combo Immune Therapies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.